-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOVIVA SPECIALTY THERAPEUTICS RECEIVES FDA NEW DRUG APPLICATION ACCEPTANCE FOR ZOLIFLODACIN, A FIRST-IN-CLASS ORAL ANTIBIOTIC FOR UNCOMPLICATED GONORRHEA IN ADULTS

Reuters·06/10/2025 10:00:00

Please log in to view news